The COVID-19 pandemic is scary, and the situation continues to evolve.  Lung cancer patients and families may have little understanding of COVID-19 testing or how it may affect patient care.  And there is plenty of confusion out there!

For our next chat, “COVID-19 testing and lung cancer: Where we stand today,” we will discuss these concerns with pulmonary pathologists and molecular pathologists, who are on the cutting edge of COVID-19 test development and use.

Please join #LCSM Chat Thursday, May 7, 2020, at 8 pm Eastern time (5 pm Pacific) to discuss COVID-19 testing and lung cancer.  Pathologist Dr. Timothy Craig Allen (@TimAllenMDJD) will moderate our discussion using the following questions:

• T1: What tests are used to determine if a patient currently has COVID-19? Are they all equally accurate?
• T2: What tests are used to determine if a patient has previously had COVID-19? Are they all equally accurate?
• T3: Can an antibody test tell if a person is now immune to, and no longer infectious with,  COVID-19? If not, why?
• T4: Why might someone be unable to get a lung biopsy during the pandemic?
• T5: What tests might doctors use to diagnose lung cancer or assess cancer progression if a biopsy is not possible?

Please join us, and bring your experiences and wisdom!  Remember to include #LCSM in ALL your tweets so the other chat participants can see them. You can read a primer on participating in the chat here.